Relmada Therapeutics Inc. Common Stock (RLMD)

Stock · NASDAQ · Health Care

$4.33as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Resistance level

$6.28

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

RLMD
Relmada Therapeutics Inc. Common Stock
$4.33
▼ 4.20%
Market cap $563.26MP/E —
ARVN
Arvinas Inc. Common Stock
$9.16
▼ 0.87%
Market cap $567.55MP/E 62.96
$6.97$14.51
SGMT
Sagimet Biosciences Inc. Series A Common Stock
$10.55
▼ 1.86%
Market cap $539.71MP/E —
$4.5$11.15
CRMD
CorMedix Inc. Common Stock
$8.31
▼ 0.06%
Market cap $589.17MP/E 3.53
$6.13$14.96
MPLT
MapLight Therapeutics Inc. Common Stock
$12.64
▲ 0.80%
Market cap $602.19MP/E —
$9.1$40.43
CBIO
Crescent Biopharma Inc. Common Stock
$17.74
▼ 0.14%
Market cap $610.27MP/E —
$8.72$27.41
OVID
Ovid Therapeutics Inc. Common Stock
$2.81
▼ 4.10%
Market cap $494.60MP/E —
$1.12$3.11

Symbol	Market cap	P/E ratio	Price	1D	52-week range
RLMD Relmada Therapeutics Inc. Common Stock	$563.26M	—	$4.33	▼ 4.20%
ARVN Arvinas Inc. Common Stock	$567.55M	62.96	$9.16	▼ 0.87%	$6.97$14.51
SGMT Sagimet Biosciences Inc. Series A Common Stock	$539.71M	—	$10.55	▼ 1.86%	$4.5$11.15
CRMD CorMedix Inc. Common Stock	$589.17M	3.53	$8.31	▼ 0.06%	$6.13$14.96
MPLT MapLight Therapeutics Inc. Common Stock	$602.19M	—	$12.64	▲ 0.80%	$9.1$40.43
CBIO Crescent Biopharma Inc. Common Stock	$610.27M	—	$17.74	▼ 0.14%	$8.72$27.41
OVID Ovid Therapeutics Inc. Common Stock	$494.60M	—	$2.81	▼ 4.10%	$1.12$3.11

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.